Home > P&MM (Current issue) > News | Search

Prescribing & Medicines Management
Issue no 5, p1
September/October 2003

This article
Reprint
Photocopy


News summary


Electronic transmission of prescriptions put on hold

Government plans to introduce national electronic transmission of prescriptions (ETP) in England have hit a set back after an independent evaluation of the three pilots testing the system.

The evaluation report concluded that ETP is technically viable but it did not recommend that any of the three pilots be the model for the future.

But despite the evaluation report, which was co-ordinated by the Sowerby Centre for Health Informatics in Newcastle, the Department of Health confirmed that it still supports the principle of ETP.

In a statement a spokesman said that the “functionality” of ETP, the way that the system works, will be included in the development of the integrated care record service (ICRS) which is the shared electronic patient record.

He explained: “During the development of the emerging ETP strategy, it was agreed that elements of ETP functionality would be best included within the parameters of ICRS. The solution for the remaining elements of the ETP programme will be decided in due course.”

The National Pharmaceutical Association was disappointed that the Government has decided to include ETP as part of the ICRS and was not pursuing it as a separate project which many people had expected following the establishment of the pilots.

NPA commercial director Richard Maw said: “I think for the time being this is a nail in the coffin of ETP being rolled out nationally. As part of the ICRS the DoH will be focusing on the clinical elements of ETP which will include details of what the patient was prescribed and what was dispensed, which isn’t really one of the big winners of the initiative as far as medicines management is concerned.

“From a medicines management perspective the biggest benefit of ETP is the ease of transfer of prescription from the GP to the pharmacist and from the pharmacist to the Prescription Pricing Authority.”

Daniel Lee managing director of Pharmacy2U, one of the companies involved in the ETP pilots, said: “The evaluation report said that ETP was technically viable which is what it is all about. There were some technical problems in the beginning. If they had come back 12 months later they would have seen huge benefits. I think it will be used in the future. The national ICRS will have this huge data spine and ETP will be part of that.”

The ETP pilot evaluation report said that ETP was slow to get going because of technical difficulties and problems recruiting patients.

The need to gain signed permission from each patient was time consuming and could hamper wider introduction of the scheme, it pointed out.

But pharmacist and GP criticisms of the system were based mainly on temporary problems with new software and processes which, the report suggested, could be overcome with additional development and training.

And it added that pharmacists running prescription collection services remained confident that ETP would save time.

Separate schemes are underway in Wales and Scotland.

Back to Top


Home | Journals | News | Notice-board | Search | Site Map | Contact us

©The Pharmaceutical Journal